Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) has emerged as the preferred vector for targeting gene expression to the retina. Subretinally injected AAV can efficiently transduce retinal pigment epithelium and photoreceptors in primate retina. Inner and middle primate retina can be transduced by intravitreally delivered AAV, but with low efficiency. This is due to dilution of vector, potential neutralization of capsid because it is not confined to the immune-privileged retinal compartment, and the presence of the inner limiting membrane (ILM), a barrier separating the vitreous from the neural retina. We here describe a novel "subILM" injection method that addresses all three issues. Specifically, vector is placed in a surgically induced, hydrodissected space between the ILM and neural retina. In an initial experiment, we injected viscoelastic (Healon(®)), a substance we confirmed was biocompatible with AAV, to create a subILM bleb and subsequently injected AAV2-GFP into the bleb after irrigation with basic salt solution. For later experiments, we used a Healon-AAV mixture to place single, subILM injections. In all cases, subILM delivery of AAV was well tolerated-no inflammation or gross structural changes were observed by ophthalmological examination or optical coherence tomography. In-life fluorescence imaging revealed profound transgene expression within the area of the subILM injection bleb that persisted for the study duration. Uniform and extensive transduction of retinal ganglion cells (RGCs) was achieved in the areas beneath the subILM bleb. Transduction of Müller glia, ON bipolar cells, and photoreceptors was also observed. Robust central labeling from green fluorescent protein-expressing RGCs confirmed their continued survival, and was observed in the lateral geniculate nucleus, the superior colliculus, and the pretectum. Our results confirm that the ILM is a major barrier to transduction by AAV in primate retina and that, when it is circumvented, the efficiency and depth to which AAV2 promotes transduction of multiple retinal cell classes are greatly enhanced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Dacey, D. M., Liao, H.-W., Peterson, B. B., Robinson, F. R., Smith, V. C., Pokorny, J., Yau, K.-W., & Gamlin, P. D. (2005) · Nature · doi:10.1038/nature03387 · Cited by 1,333 · cited 1×
“However, it is known that many outer stratifying ipRGCs (M1 homologous cells) are displaced to the inner nuclear layer, and it is likely that our subILM-delivered vector did not efficiently transduce these displaced ipRGCs.(60,61) Further, in rodents, M1 cells project to the SCN and the shell of the PON to mediate cir…”
BackgroundSelf-citationCentral projections of melanopsin‐expressing retinal ganglion cells in the mouse
Hattar, S., Kumar, M., Park, A., Tong, P., Tung, J., Yau, K., & Berson, D. M. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.20970 · Cited by 996 · cited 1×
“Further, in rodents, M1 cells project to the SCN and the shell of the PON to mediate circadian photoentrainment (SCN) and the pupillary light reflex (PON).(62,63) Therefore, it is tempting to speculate that in primates, the outer stratifying ipRGCs (M1 homologous cells) account for much of the projection to the SCN an…”
BackgroundHauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Self-citationMacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
Long-Term Effect of Gene Therapy on Leber’s Congenital Amaurosis
Bainbridge, J. W. B., Mehat, M. S., Sundaram, V., Robbie, S. J., Barker, S. E., Ripamonti, C., Georgiadis, A., Mowat, F. M., Beattie, S. G., Gardner, P. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414221 · Cited by 743
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734 · cited 7×
“Interaction of the capsid with heparan sulfate proteoglycan (HSPG), as shown by binding affinity of the capsid to a heparin column, is a strict requirement for intravitreally mediated transduction when the ILM is intact.64 Interestingly, these two capsid mutants retain the ability to bind heparin, but with lower affin…”
BackgroundResultInfluentialInner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
A comprehensive review of retinal gene therapy
Boye, S. E., Boye, S. L., Lewin, A. S., & Hauswirth, W. W. (2013) · Molecular Therapy · doi:10.1038/mt.2012.280 · Cited by 262
Self-citationGene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.025 · Cited by 230 · cited 1×
“Intravitreal injection is being used to target AAV to retinal ganglion cells (RGCs) of patients with Leber hereditary optic neuropathy (LHON) in ongoing clinical trials.(18) However, emerging data highlight limitations in this approach in primates, including humans.”
MethodJacobson, S. G., Acland, G. M., Aguirre, G. D., Aleman, T. S., Schwartz, S. B., Cideciyan, A. V., Zeiss, C. J., Komaromy, A. M., Kaushal, S., Roman, A. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.005 · Cited by 224 · cited 1×
“Both vectors were purified and titered according to previously published methods.(42,43) The final concentration of AAV2-CBA-GFP was 1.”
MethodSelf-citationAAV Capsid Structure and Cell Interactions
Agbandje-McKenna, M., & Kleinschmidt, J. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-370-7_3 · Cited by 215 · cited 1×
“AAVs use glycans as primary receptors for cellular recognition and internalization, and the hyaluronic acid in Healon is a glycosoaminoglycan (GAG).(53) We therefore preincubated AAV2 with Healon and then performed an in vitro transduction assay in 661W cone-derived photoreceptor cells.”
MethodIntravitreal injection of AAV2 transduces macaque inner retina
Yin, L., Greenberg, K., Hunter, J. J., Dalkara, D., Kolstad, K. D., Masella, B. D., Wolfe, R., Visel, M., Stone, D., Libby, R. T., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6250 · Cited by 212 · cited 8×
“When the ILM is physically degraded by enzymatic digestion or lacks structural integrity because of genetic manipulation, AAV transduction in both rodents and NHP may be improved.(19,36,37) However, the long-term implications of such disruption for the structure/function of the neural retina have not been investigated.”
BackgroundMethodResultInfluentialRetinal prosthetic strategy with the capacity to restore normal vision
Nirenberg, S., & Pandarinath, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207035109 · Cited by 207
Kotterman, M. A., Yin, L., Strazzeri, J. M., Flannery, J. G., Merigan, W. H., & Schaffer, D. V. (2015) · Gene Therapy · doi:10.1038/gt.2014.115 · Cited by 169 · cited 3×
“At this point, we cannot determine whether a subILM injection alone (of Healon–AAV) without reflux results in an increase in nAbs because the second and third animals (EN-28 and EV-44) both received intravitreal injections of AAV2 in their left eyes, which in and of itself leads to an increase in the formation of neut…”
BackgroundTargeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
Kay, C. N., Ryals, R. C., Aslanidi, G. V., Min, S. H., Ruan, Q., Sun, J., Dyka, F. M., Kasuga, D., Ayala, A. E., Van Vliet, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062097 · Cited by 168
Self-citationMowat, F. M., Gornik, K. R., Dinculescu, A., Boye, S. L., Hauswirth, W. W., Petersen-Jones, S. M., & Bartoe, J. T. (2014) · Gene Therapy · doi:10.1038/gt.2013.64 · Cited by 108 · cited 1×
“In dog, AAV2 transduces RGCs and Müller glia throughout the retina with low efficiency, and with higher efficiency in regions surrounding large blood vessels.(50) In macaques, AAV2 transduction is restricted primarily to the inner retina within the foveal ring.”
BackgroundSelf-citationAAV9 targets cone photoreceptors in the nonhuman primate retina
Vandenberghe, L. H., Bell, P., Maguire, A. M., Xiao, R., Hopkins, T. B., Grant, R., Bennett, J., & Wilson, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053463 · Cited by 97
Retinoschisin gene therapy in photoreceptors, Müller glia or all retinal cells in the Rs1h−/− mouse
Byrne, L. C., Öztürk, B. E., Lee, T., Fortuny, C., Visel, M., Dalkara, D., Schaffer, D. V., & Flannery, J. G. (2014) · Gene Therapy · doi:10.1038/gt.2014.31 · Cited by 96
Pellissier, L. P., Quinn, P. M., Alves, C. H., Vos, R. M., Klooster, J., Flannery, J. G., Heimel, J. A., & Wijnholds, J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv062 · Cited by 86
Boye, S. L., Bennett, A., Scalabrino, M. L., McCullough, K. T., Van Vliet, K., Choudhury, S., Ruan, Q., Peterson, J., Agbandje-McKenna, M., & Boye, S. E. (2016) · Journal of Virology · doi:10.1128/jvi.00200-16 · Cited by 79
Self-citationYe, G.-J., Budzynski, E., Sonnentag, P., Miller, P. E., Sharma, A. K., Ver Hoeve, J. N., Howard, K., Knop, D. R., Neuringer, M., McGill, T., et al. (2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2015.076 · Cited by 53
AAV‐mediated gene delivery in Dp71‐null mouse model with compromised barriers
Vacca, O., Darche, M., Schaffer, D. V., Flannery, J. G., Sahel, J., Rendon, A., & Dalkara, D. (2014) · Glia · doi:10.1002/glia.22617 · Cited by 48
Research works printed but not linked: 40
- 10.1073/pnas.0807027105 · DOI · Paper page
- 10.1172/JCI57377 · DOI · Paper page
- 10.1126/scitranslmed.3002865 · DOI · Paper page
- 10.1001/archophthalmol.2011.298 · DOI · Paper page
- 10.1056/NEJMoa1412965 · DOI · Paper page
- 10.1016/j.ophtha.2012.11.048 · DOI · Paper page
- 10.1089/hum.2012.125 · DOI · Paper page
- 10.1126/scitranslmed.3002103 · DOI · Paper page
- 10.1001/archopht.1968.03850040051014 · DOI · Paper page
- 10.1001/archopht.1986.01050160132029 · DOI · Paper page
- 10.1016/j.crvi.2014.01.002 · DOI · Paper page
- 10.1038/nn.2117 · DOI · Paper page
- 10.1038/mt.2011.69 · DOI · Paper page
- 10.1073/pnas.1414162111 · DOI · Paper page
- 10.1371/journal.pbio.1002143 · DOI · Paper page
- 10.1038/mt.2015.121 · DOI · Paper page
- 10.1038/mt.2011.62 · DOI · Paper page
- 10.1093/hmg/ddv341 · DOI · Paper page
- Matsumoto B, , Blanks JC, , Ryan SJ. Topographic variations in the rabbit and primate internal limiting membrane. Invest Ophthalmol Vis Sci, 1984; 25:71–82.
- Cehajic-Kapetanovic J, , Le Goff MM, , Allen A, et al. Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2. Mol Vis, 2011; 17:1771–1783.
- 10.1097/IAE.0b013e318213618c · doi:10.1097/iae.0b013e318213618c
- 10.1016/j.ajo.2013.01.023 · doi:10.1016/j.ajo.2013.01.023
- 10.1016/j.ophtha.2010.02.011 · doi:10.1016/j.ophtha.2010.02.011
- 10.1001/jamaophthalmol.2013.2176 · doi:10.1001/jamaophthalmol.2013.2176
- 10.1089/hum.2005.16.551 · DOI · Paper page
- Ryals RC, , Boye SL, , Dinculescu A, et al. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines. Mol Vis, 2011; 17:1090–1102.
- Snodderly DM, , Auran JD, , Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci, 1984; 25:674–685.
- Guerin CJ, , Anderson DH, , Fisher SK. Changes in intermediate filament immunolabeling occur in response to retinal detachment and reattachment in primates. Invest Ophthalmol Vis Sci, 1990; 31:1474–1482.
- 10.1002/cne.23555 · DOI · Paper page
- 10.1006/mcne.2002.1168 · DOI · Paper page
- 10.1038/mt.2014.154 · DOI · Paper page
- Comander J Carvalho LS Xiao R et al. Characterization of the limitations to gene transfer and associated inflammation following intravitreal AAV injection in nonhuman primates. Association for Research in Vision and Ophthalmology Vol. 771: C0060. Seattle WA April 30–May 5 2016.
- 10.1136/bjo.2007.133041 · doi:10.1136/bjo.2007.133041
- 10.1016/j.ajo.2004.06.088 · doi:10.1016/j.ajo.2004.06.088
- 10.1016/j.neuron.2009.04.014 · DOI · Paper page
- 10.1152/jn.1971.34.1.139 · doi:10.1152/jn.1971.34.1.139
- 10.1016/S0896-6273(02)01143-1 · DOI · Paper page
- 10.1002/cne.23995 · DOI · Paper page
- 10.1126/science.1069609 · DOI · Paper page
- 10.1016/0042-6989(92)90235-B · DOI · Paper page
Cited by
Technique of retinal gene therapy: delivery of viral vector into the subretinal space
Xue, K., Groppe, M., Salvetti, A. P., & MacLaren, R. E. (2017) · Eye · doi:10.1038/eye.2017.158 · Cited by 191
Garafalo, A. V., Cideciyan, A. V., Héon, E., Sheplock, R., Pearson, A., WeiYang Yu, C., Sumaroka, A., Aguirre, G. D., & Jacobson, S. G. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100827 · Cited by 173
Noninvasive gene delivery to foveal cones for vision restoration
Khabou, H., Garita-Hernandez, M., Chaffiol, A., Reichman, S., Jaillard, C., Brazhnikova, E., Bertin, S., Forster, V., Desrosiers, M., Winckler, C., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96029 · Cited by 124
“We and others have shown transduction of macaque cones using AAV variants with ubiquitous promoters (16, 29–32), but achieving cone transduction by vitreally administered AAV has only been possible at high doses, leading to inflammation (16, 29).”
BackgroundSeeing the light after 25 Years of retinal gene therapy
Trapani, I., & Auricchio, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.06.006 · Cited by 124
Gene therapy for inherited retinal diseases: Progress and possibilities
Hu, M. L., Edwards, T. L., O’Hare, F., Hickey, D. G., Wang, J.-H., Liu, Z., & Ayton, L. N. (2021) · Clinical and Experimental Optometry · doi:10.1080/08164622.2021.1880863 · Cited by 118
Metadata
- Authors
- Boye, S. E., Alexander, J. J., Witherspoon, C. D., Boye, S. L., Peterson, J. J., Clark, M. E., Sandefer, K. J., Girkin, C. A., Hauswirth, W. W., & Gamlin, P. D.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2016-08
- Volume
- 27
- Issue
- 8
- Pages
- 580-597
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2495536352
- Cited by
- 78
- References
- 24
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.